INVESTORS in Craneware will be right to feel a little bit pleased with themselves at present.

As well as seeing their shares in the software company steadily rise over the last year, helped along the way by a £15 million share buyback announced in January, they have just seen the company book nearly a full year’s worth of revenue in the first half of its current year.

Taking recent major contract wins into consideration, including two since the half-year reporting period concluded, chief executive Keith Neilson declared yesterday that the company was on course for a record year of sales and revenue growth.

And there would appear to be little sign of its outlook changing, despite a shifting political backdrop in its core US market where issues such as healthcare, taxation and now trade protectionism are commanding international headlines. Nor would he appear to be overly troubled by Brexit, which many Scottish-based technology companies fear will choke off the supply of software engineers and developers when people can no longer freely move from the European Union (EU) into the UK.

As Mr Neilson noted, Craneware is reaping the benefits of the investment it has made in developing its suite of revenue and data management products in recent years. Crucially, these solutions are in high demand among healthcare providers in the US, which Mr Neilson said are increasingly aware of the difference better data management can make to their financial performance – and the service they provide to their patients.